Prokaryotics, Inc.: Prokaryotics and Basilea enter collaboration to develop a novel broad-spectrum antifungal for severe invasive infections

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives ...
The Malaysian Reserve

Prokaryotics and Basilea enter collaboration to develop a novel broad-spectrum antifungal for severe invasive infections

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel ...
EurekAlert!

The mechanical ratchet: A new mechanism of cell division uncovered

Cell division is an essential process for all life on earth, yet the exact mechanisms by which cells divide during early ...
EuropaWire

Basilea Expands Anti-Infective Pipeline Through Antifungal Collaboration with Prokaryotics

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...